MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 11-07-2022
Allscripts Healthcare Solutions Revenue 2011-2025 | MDRX
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Allscripts Healthcare Solutions
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.5 B | 1.5 B | 1.77 B | 1.75 B | 1.81 B | 1.55 B | 1.39 B | 1.38 B | 1.37 B | 1.45 B | 1.44 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.81 B | 1.37 B | 1.54 B |
Quarterly Revenue Allscripts Healthcare Solutions
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 152 M | 151 M | 143 M | 392 M | 145 M | 141 M | 134 M | 386 M | 366 M | 369 M | 381 M | 414 M | 408 M | 411 M | 399 M | 442 M | 432 M | 526 M | 514 M | 517 M | 449 M | 426 M | 413 M | 425 M | 392 M | 387 M | 346 M | 346 M | 354 M | 352 M | 335 M | 341 M | 345 M | 351 M | 340 M | 351 M | 330 M | 345 M | 347 M | - | 361 M | 370 M | 365 M | - | 364 M | 357 M | 335 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 526 M | 134 M | 354 M |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Health information services industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Covetrus
CVET
|
4.58 B | - | - | $ 2.94 B |  USA |
 |
Cerner Corporation
CERN
|
5.76 B | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
339 M | - | 4.4 % | $ 133 M | USA |
 |
Accolade
ACCD
|
170 M | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
147 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
673 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
668 M | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
19.6 M | - | - | $ 102 M | USA |
 |
Change Healthcare
CHNG
|
3.09 B | - | - | $ 9.03 B | USA |
 |
Evolent Health
EVH
|
382 M | $ 4.15 | 0.24 % | $ 389 M | USA |
 |
Health Catalyst
HCAT
|
307 M | $ 2.43 | 2.1 % | $ 146 M | USA |
 |
HealthStream
HSTM
|
292 M | $ 23.69 | -0.59 % | $ 720 M | USA |
 |
MTBC
MTBC
|
111 M | - | -0.58 % | $ 51.7 M | USA |
 |
Akerna Corp.
KERN
|
20.5 M | - | - | $ 161 M | USA |
 |
HealthEquity
HQY
|
262 M | $ 93.67 | 1.32 % | $ 8.01 B | USA |
 |
American Well Corporation
AMWL
|
254 M | $ 4.59 | 0.44 % | $ 68.8 M | USA |
 |
OptimizeRx Corporation
OPRX
|
71.5 M | $ 12.53 | -1.8 % | $ 215 M | USA |
 |
GoodRx Holdings
GDRX
|
792 M | $ 2.76 | -0.36 % | $ 1.06 B | USA |
 |
So-Young International
SY
|
-1.52 M | $ 2.65 | -5.54 % | $ 210 M |  China |
 |
Progyny
PGNY
|
298 M | $ 25.95 | 1.72 % | $ 2.23 B | USA |
 |
Omnicell
OMCL
|
1.11 B | $ 46.4 | 1.34 % | $ 2.14 B | USA |
 |
1Life Healthcare
ONEM
|
623 M | - | - | $ 3.37 B | USA |
 |
Phreesia
PHR
|
356 M | $ 17.12 | 1.63 % | $ 934 M | USA |
 |
Premier
PINC
|
263 M | $ 28.26 | - | $ 2.33 B | USA |
 |
R1 RCM
RCM
|
1.47 B | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
67 M | - | -46.64 % | $ 10.4 M | USA |
 |
Zhongchao
ZCMD
|
16.3 M | $ 0.48 | -9.76 % | $ 2.5 M | China |
 |
NextGen Healthcare
NXGN
|
557 M | - | - | $ 1.6 B | USA |
 |
Schrödinger
SDGR
|
208 M | $ 18.38 | - | $ 1.34 B | USA |
 |
Signify Health
SGFY
|
184 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
17.9 M | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
2.57 B | $ 7.12 | -1.66 % | $ 1.21 B | USA |
 |
10x Genomics
TXG
|
619 M | $ 16.61 | -0.51 % | $ 1.95 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
300 M | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
2.36 B | $ 224.44 | 0.51 % | $ 36 B | USA |
 |
SCWorx Corp.
WORX
|
2.99 M | $ 0.2 | 0.3 % | $ 292 K | USA |